Gerresheimer AG (GRRMF)
OTCMKTS · Delayed Price · Currency is USD
51.41
0.00 (0.00%)
Oct 9, 2025, 8:00 PM EDT
Gerresheimer AG Revenue
Gerresheimer AG had revenue of 560.68M EUR in the quarter ending August 31, 2025, with 12.47% growth. This brings the company's revenue in the last twelve months to 2.25B, up 11.83% year-over-year. In the fiscal year ending November 30, 2024, Gerresheimer AG had annual revenue of 2.04B with 2.28% growth.
Revenue (ttm)
2.25B EUR
Revenue Growth
+11.83%
P/S Ratio
0.44
Revenue / Employee
185.33K EUR
Employees
12,142
Market Cap
1.15B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Nov 30, 2024 | 2.04B | 45.42M | 2.28% |
Nov 30, 2023 | 1.99B | 173.39M | 9.54% |
Nov 30, 2022 | 1.82B | 319.09M | 21.30% |
Nov 30, 2021 | 1.50B | 79.22M | 5.58% |
Nov 30, 2020 | 1.42B | 26.53M | 1.91% |
Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 105.45M |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Jushi Holdings | 256.36M |
AMJ Global Technology | 39.00 |
Gerresheimer AG News
- 1 day ago - Gerresheimer AG (GRRMF) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... - GuruFocus
- 1 day ago - Q3 2025 Gerresheimer AG Earnings Call Transcript - GuruFocus
- 1 day ago - Gerresheimer AG (GRRMY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Gerresheimer's shares fall 11% after another outlook cut - Reuters
- 3 days ago - Gerresheimer cuts 2025 outlook again as Q3 disappoints - Reuters
- 17 days ago - Gerresheimer shares tank as financial regulator suspects accounting flaws - Reuters
- 6 weeks ago - Gerresheimer CFO resigns unexpectedly, successor to take over from September - Reuters
- 7 weeks ago - Activist investor wants review at Gerresheimer after taking stake - Reuters